RNAZ Insider Trading

Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Recent Form 4 Transactions

36 shown
DateInsiderRoleActionSharesPriceValue
Sep 9, 2026Fitzgerald Thomas AChief Financial Officer, DirectorGrant(A)185K$0
Aug 3, 2026Defj, LLC10% OwnerConversion(C)11.8M
Aug 3, 2026Defj, LLC10% OwnerConversion(C)2.0M
Aug 3, 2026Defj, LLC10% OwnerConversion(C)1K$0
Aug 3, 2026Defj, LLC10% OwnerConversion(C)202$0
Jun 14, 2024Calais PhilippeDirectorGrant(A)70K$0
Jun 14, 2024Fitzgerald Thomas AInterim CEO, CFO, DirectorGrant(A)650K$0
Jun 14, 2024Manting ErikDirectorGrant(A)70K$0
Jun 14, 2024Marquet MagdaDirectorGrant(A)70K$0
Sep 28, 2023Dudley Robert MichaelChief Executive Officer, DirectorBuy(P)98K$0.51$50K
Sep 28, 2023Fitzgerald Thomas AChief Financial Officer, DirectorBuy(P)49K$0.51$25K
Jun 21, 2023Dudley Robert MichaelChief Executive Officer, DirectorBuy(P)12K$2.65$32K
Jun 20, 2023Dudley Robert MichaelChief Executive Officer, DirectorBuy(P)7K$2.55$17K
Jun 9, 2023Dudley Robert MichaelChief Executive Officer, DirectorBuy(P)19K$2.76$52K
May 19, 2023Calais PhilippeDirectorGrant(A)45K$0
May 19, 2023Dudley Robert MichaelChief Executive Officer, DirectorGrant(A)735K$0
May 19, 2023Fitzgerald Thomas AChief Financial Officer, DirectorGrant(A)300K$0
May 19, 2023Marquet MagdaDirectorGrant(A)45K$0
May 19, 2023Manting ErikDirectorGrant(A)45K$0
May 10, 2023Calais PhilippeDirectorGrant(A)10K$0
May 10, 2023Marquet MagdaDirectorGrant(A)10K$0
May 10, 2023Manting ErikDirectorGrant(A)10K$0
Dec 12, 2022Medarova ZdravkaChief Technology Officer, 10% OwnerGrant(A)60K$0
Dec 12, 2022Dudley Robert MichaelChief Executive Officer, Director, 10% OwnerGrant(A)135K$0
Dec 12, 2022Fitzgerald Thomas AChief Financial Officer, DirectorGrant(A)100K$0
Sep 14, 2022Dudley Robert MichaelChief Executive Officer, Director, 10% OwnerBuy(P)20K$1.15$23K
Jun 22, 2022Manting ErikDirectorGrant(A)10K$0
Jun 22, 2022Marquet MagdaDirectorGrant(A)10K$0
Jun 22, 2022Calais PhilippeDirectorGrant(A)10K$0
Jun 16, 2022Fitzgerald Thomas AChief Financial Officer, DirectorBuy(P)12K$1.27$15K
May 31, 2022Dudley Robert MichaelChief Executive Officer, Director, 10% OwnerBuy(P)2K$1.87$4K
May 27, 2022Dudley Robert MichaelChief Executive Officer, Director, 10% OwnerBuy(P)28K$1.84$52K
Mar 1, 2022Fitzgerald Thomas AChief Financial Officer, DirectorGrant(A)52K$0
Feb 1, 2022Medarova ZdravkaChief Technology Officer, 10% OwnerGrant(A)33K$0
Feb 1, 2022Dudley Robert MichaelChief Executive Officer, Director, 10% OwnerGrant(A)135K$0
Feb 1, 2022Fitzgerald Thomas AChief Financial Officer, DirectorGrant(A)33K$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Transcode Therapeutics, Inc., SEC CIK 0001829635. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under RNAZ and shows every filing by that issuer.

Coverage: Form 4 filings indexed 2006-01-022026-09-12. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).